Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis Volume 13, 2012 - Issue 5
Journal homepage
830
Views
60
CrossRef citations to date
0
Altmetric
Research Article

TDP-43 plasma levels are higher in amyotrophic lateral sclerosis

Esther VerstraeteDepartment of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht
,
H. Bea KuiperijDepartment of Neurology;Department of Laboratory Medicine, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands
,
Marka M. van BlitterswijkDepartment of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht
,
Jan H. VeldinkDepartment of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht
,
H. Jurgen SchelhaasDepartment of Neurology
,
Leonard H. van den BergDepartment of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, UtrechtCorrespondence[email protected]
&
Marcel M. VerbeekDepartment of Neurology;Department of Laboratory Medicine, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands
 show all
Pages 446-451 | Received 07 Mar 2012, Accepted 11 Jun 2012, Published online: 08 Aug 2012

Citations (60)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Arens Taga & Nicholas J. Maragakis. (2018) Current and emerging ALS biomarkers: utility and potential in clinical trials. Expert Review of Neurotherapeutics 18:11, pages 871-886.
Read now
. (2018) ALSUntangled 45: Antiretrovirals. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 630-634.
Read now
H. Blasco, P. Vourc’h, P. F. Pradat, P. H. Gordon, C. R. Andres & P. Corcia. (2016) Further development of biomarkers in amyotrophic lateral sclerosis. Expert Review of Molecular Diagnostics 16:8, pages 853-868.
Read now
Kay A. Lawton, Meredith V. Brown, Danny Alexander, Zhen Li, Jacob E. Wulff, Robert Lawson, Matt Jaffa, Mike V. Milburn, John A. Ryals, Robert Bowser, Merit E. Cudkowicz & James D. Berry. (2014) Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 362-370.
Read now
Emily Feneberg, Petra Steinacker, Stefan Lehnert, Anja Schneider, Paul Walther, Dietmar R. Thal, Miriam Linsenmeier, Albert C. Ludolph & Markus Otto. (2014) Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 351-356.
Read now

Articles from other publishers (55)

Christopher E. Bauer, Valentinos Zachariou, Tiffany L. Sudduth, Linda J. Van Eldik, Gregory A. Jicha, Peter T. Nelson, Donna M. Wilcock & Brian T. Gold. (2023) Plasma TDP‐43 levels are associated with neuroimaging measures of brain structure in limbic regions. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 15:2.
Crossref
Daehwan Kim, Dobri D. Kiprov, Connor Luellen, Michael Lieb, Chao Liu, Etsuko Watanabe, Xiaoyue Mei, Kaitlin Cassaleto, Joel Kramer, Michael J. Conboy & Irina M. Conboy. (2022) Old plasma dilution reduces human biological age: a clinical study. GeroScience 44:6, pages 2701-2720.
Crossref
Frederic Sampedro, Saul Martínez-Horta, Jesus Pérez-Pérez, Rocío Pérez-González, Andrea Horta-Barba, Antonia Campolongo, Cristina Izquierdo, Ignacio Aracil-Bolaños, Elisa Rivas, Arnau Puig-Davi, Javier Pagonabarraga, Beatriz Gómez-Ansón & Jaime Kulisevsky. (2022) Plasma TDP-43 Reflects Cortical Neurodegeneration and Correlates with Neuropsychiatric Symptoms in Huntington’s Disease. Clinical Neuroradiology 32:4, pages 1077-1085.
Crossref
Sadhana Nirwal, Preethi Saravanan, Akarsh Bajpai, Vini D. Meshram, Gembali Raju, Waghela Deeksha, Ganesan Prabusankar & Basant K Patel. (2022) In Vitro Interaction of a C-Terminal Fragment of TDP-43 Protein with Human Serum Albumin Modulates Its Aggregation. The Journal of Physical Chemistry B 126:45, pages 9137-9151.
Crossref
Miguel A. Rubio, Mireia Herrando-Grabulosa, Roser Velasco, Israel Blasco, Monica Povedano & Xavier Navarro. (2022) TDP-43 Cytoplasmic Translocation in the Skin Fibroblasts of ALS Patients. Cells 11:2, pages 209.
Crossref
Yuta Kojima, Takashi Kasai, Yu-ichi Noto, Takuma Ohmichi, Harutsugu Tatebe, Takamasa Kitaoji, Yukiko Tsuji, Fukiko Kitani-Morii, Makiko Shinomoto, David Allsop, Satoshi Teramukai, Toshiki Mizuno & Takahiko Tokuda. (2021) Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics. PLOS ONE 16:11, pages e0260323.
Crossref
Elena Rita Simula, Giannina Arru, Ignazio Roberto Zarbo, Paolo Solla & Leonardo A. Sechi. (2021) TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients. Viruses 13:11, pages 2301.
Crossref
Taylor D. Pobran, David Yang, Ian R.A. Mackenzie & Mari L. DeMarco. (2021) Aptamer-based enrichment of TDP-43 from human cells and tissues with quantification by HPLC-MS/MS. Journal of Neuroscience Methods 363, pages 109344.
Crossref
Mariachiara Manoccio, Marco Esposito, Elisabetta Primiceri, Angelo Leo, Vittorianna Tasco, Massimo Cuscunà, Dmitry Zuev, Yali Sun, Giuseppe Maruccio, Alessandro Romano, Angelo Quattrini, Giuseppe Gigli & Adriana Passaseo. (2021) Femtomolar Biodetection by a Compact Core–Shell 3D Chiral Metamaterial. Nano Letters 21:14, pages 6179-6187.
Crossref
Heather M. Wilkins, Mazen M. Dimachkie & Abdulbaki Agbas. 2021. Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis 105 120 .
Yuting Ren, Siyuan Li, Siyu Chen, Xiaosun Sun, Fei Yang, Hongfen Wang, Mao Li, Fang Cui & Xusheng Huang. (2021) TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 12.
Crossref
Han-Jou Chen & Jacqueline C. Mitchell. (2021) Mechanisms of TDP-43 Proteinopathy Onset and Propagation. International Journal of Molecular Sciences 22:11, pages 6004.
Crossref
Marco Baralle & Maurizio Romano. (2021) Characterization of the human TARDBP gene promoter. Scientific Reports 11:1.
Crossref
Yiyun Jin, Devkee Mahesh Vadukul, Dimitra Gialama, Ying Ge, Rebecca Thrush, Joe Thomas White & Francesco Antonio Aprile. (2021) The Diagnostic Potential of Amyloidogenic Proteins. International Journal of Molecular Sciences 22:8, pages 4128.
Crossref
Elisa Conti, Gessica Sala, Susanna Diamanti, Marco Casati, Christian Lunetta, Francesca Gerardi, Claudia Tarlarini, Lorena Mosca, Nilo Riva, Yuri Falzone, Massimo Filippi, Ildebrando Appollonio, Carlo Ferrarese & Lucio Tremolizzo. (2021) Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis. Scientific Reports 11:1.
Crossref
Sahara J Cathcart, Stanley H Appel, Leif E Peterson, Ericka P Greene, Suzanne Z Powell, Anithachristy S Arumanayagam, Andreana L Rivera & Matthew D Cykowski. (2021) Fast Progression in Amyotrophic Lateral Sclerosis Is Associated With Greater TDP-43 Burden in Spinal Cord. Journal of Neuropathology & Experimental Neurology 80:8, pages 754-763.
Crossref
Emma L. van der Ende & John C. van Swieten. 2021. Frontotemporal Dementias. Frontotemporal Dementias 123 139 .
Shweta Modgil, Radhika Khosla, Abha Tiwari, Kaushal Sharma & Akshay Anand. (2020) Association of Plasma Biomarkers for Angiogenesis and Proteinopathy in Indian Amyotrophic Lateral Sclerosis Patients. Journal of Neurosciences in Rural Practice 11, pages 573-580.
Crossref
Ruaridh Cameron Smail & Neil Simon. (2020) Clinical Controversies in Amyotrophic Lateral Sclerosis. EMJ Neurology, pages 80-92.
Crossref
Nicholas J. Ashton, Abdul Hye, Anto P. Rajkumar, Antoine Leuzy, Stuart Snowden, Marc Suárez-Calvet, Thomas K. Karikari, Michael Schöll, Renaud La Joie, Gil D. Rabinovici, Kina Höglund, Clive Ballard, Tibor Hortobágyi, Per Svenningsson, Kaj Blennow, Henrik Zetterberg & Dag Aarsland. (2020) An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders. Nature Reviews Neurology 16:5, pages 265-284.
Crossref
Takashi Kasai, Yuta Kojima, Takuma Ohmichi, Harutsugu Tatebe, Yukiko Tsuji, Yu‐ichi Noto, Fukiko Kitani‐Morii, Makiko Shinomoto, David Allsop, Toshiki Mizuno & Takahiko Tokuda. (2019) Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS. Annals of Clinical and Translational Neurology 6:12, pages 2489-2502.
Crossref
Ann Brinkmalm, Erik Portelius, Gunnar Brinkmalm, Josef Pannee, Rahil Dahlén, Johan Gobom, Kaj Blennow & Henrik Zetterberg. (2018) Fluid‐based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases. Journal of Neurochemistry 151:4, pages 417-434.
Crossref
Hiroaki Suzuki, Yoshio Shibagaki, Seisuke Hattori & Masaaki Matsuoka. (2019) C9-ALS/FTD-linked proline–arginine dipeptide repeat protein associates with paraspeckle components and increases paraspeckle formation. Cell Death & Disease 10:10.
Crossref
Federico Verde, Vincenzo Silani & Markus Otto. (2019) Neurochemical biomarkers in amyotrophic lateral sclerosis. Current Opinion in Neurology 32:5, pages 747-757.
Crossref
Arwa A. Abugable, Julia L.M. Morris, Nelma M. Palminha, Ringaile Zaksauskaite, Swagat Ray & Sherif F. El-Khamisy. (2019) DNA repair and neurological disease: From molecular understanding to the development of diagnostics and model organisms. DNA Repair 81, pages 102669.
Crossref
Petra Steinacker, Peggy Barschke & Markus Otto. (2019) Biomarkers for diseases with TDP-43 pathology. Molecular and Cellular Neuroscience 97, pages 43-59.
Crossref
Rudolf C Hergesheimer, Anna A. Chami, Denis Reis de Assis, Patrick Vourc’h, Christian R. Andres, Philippe Corcia, Débora Lanznaster & Hélène Blasco. (2019) The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?. Brain 142:5, pages 1176-1194.
Crossref
Tomoya Ichikawa, Hajime Baba, Hitoshi Maeshima, Takahisa Shimano, Megumi Inoue, Mei Ishiguro, Seita Yasuda, Hiroko Shukuzawa, Toshihito Suzuki & Heii Arai. (2019) Serum levels of TDP-43 in late-life patients with depressive episode. Journal of Affective Disorders 250, pages 284-288.
Crossref
Nick S. Verber, Stephanie R. Shepheard, Matilde Sassani, Harry E. McDonough, Sophie A. Moore, James J. P. Alix, Iain D. Wilkinson, Tom M. Jenkins & Pamela J. Shaw. (2019) Biomarkers in Motor Neuron Disease: A State of the Art Review. Frontiers in Neurology 10.
Crossref
Georgios Pampalakis, Konstantinos Mitropoulos, Georgia Xiromerisiou, Efthymios Dardiotis, Georgia Deretzi, Maria Anagnostouli, Theodora Katsila, Michail Rentzos & George P. Patrinos. (2019) New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis. Human Mutation 40:4, pages 361-373.
Crossref
Rangariroyashe Hannah Chipika, Eoin Finegan, Stacey Li Hi Shing, Orla Hardiman & Peter Bede. (2019) Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS. Frontiers in Neurology 10.
Crossref
Marine Pons, Silvia Prieto, Laetitia Miguel, Thierry Frebourg, Dominique Campion, Carles Suñé & Magalie Lecourtois. (2018) Identification of TCERG1 as a new genetic modulator of TDP-43 production in Drosophila. Acta Neuropathologica Communications 6:1.
Crossref
Emily Feneberg, Elizabeth Gray, Olaf Ansorge, Kevin Talbot & Martin R. Turner. (2018) Towards a TDP-43-Based Biomarker for ALS and FTLD. Molecular Neurobiology 55:10, pages 7789-7801.
Crossref
Kevin Talbot, Emily Feneberg, Jakub Scaber, Alexander G. Thompson & Martin R. Turner. (2018) Amyotrophic lateral sclerosis: the complex path to precision medicine. Journal of Neurology 265:10, pages 2454-2462.
Crossref
Jui-Hao Lee, Jen-Wei Liu, Shinn-Zong Lin, Horng-Jyh Harn & Tzyy-Wen Chiou. (2018) Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis. Cell Transplantation 27:9, pages 1301-1312.
Crossref
Akihiro Sugai, Taisuke Kato, Akihide Koyama, Yuka Koike, Sou Kasahara, Takuya Konno, Tomohiko Ishihara & Osamu Onodera. (2018) Robustness and Vulnerability of the Autoregulatory System That Maintains Nuclear TDP-43 Levels: A Trade-off Hypothesis for ALS Pathology Based on in Silico Data. Frontiers in Neuroscience 12.
Crossref
Rodger Wilhite, Jessica M Sage, Abdurrahman Bouzid, Tyler Primavera & Abdulbaki Agbas. (2017) Platelet phosphorylated TDP-43: an exploratory study for a peripheral surrogate biomarker development for Alzheimer's disease. Future Science OA 3:4, pages FSO238.
Crossref
Vladimir F. Lazarev, Elena R. Mikhaylova, Irina V. Guzhova & Boris A. Margulis. (2017) Possible Function of Molecular Chaperones in Diseases Caused by Propagating Amyloid Aggregates. Frontiers in Neuroscience 11.
Crossref
Ihsan Cetin, Hamdullah Bulut & Şeref Şimsek. (2017) Elevated serum ubiquitin-proteasome pathway related molecule levels in attention deficit hyperactivity disorder. Turkish Journal of Biochemistry 42:2, pages 187-193.
Crossref
Lucas T. Vu & Robert Bowser. (2016) Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis. Neurotherapeutics 14:1, pages 119-134.
Crossref
Andreas Jeromin & Robert Bowser. 2017. Neurodegenerative Diseases. Neurodegenerative Diseases 491 528 .
Vincent Picher-Martel, Paul N. Valdmanis, Peter V. Gould, Jean-Pierre Julien & Nicolas Dupré. (2016) From animal models to human disease: a genetic approach for personalized medicine in ALS. Acta Neuropathologica Communications 4:1.
Crossref
H. Bea Kuiperij, Alexandra A.M. Versleijen, Marijke Beenes, Nicolaas A. Verwey, Luisa Benussi, Anna Paterlini, Giuliano Binetti, Charlotte E. Teunissen, Joost Raaphorst, Helenius J. Schelhaas, Benno Küsters, Yolande A.L. Pijnenburg, Roberta Ghidoni & Marcel M. Verbeek. (2016) Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study. Journal of Alzheimer's Disease 55:2, pages 585-595.
Crossref
Anna Häggmark, Jochen M. Schwenk & Peter Nilsson. (2016) Neuroproteomic profiling of human body fluids. PROTEOMICS - Clinical Applications 10:4, pages 485-502.
Crossref
Joery Goossens, Eugeen Vanmechelen, John Q Trojanowski, Virginia MY Lee, Christine Van Broeckhoven, Julie van der Zee & Sebastiaan Engelborghs. (2015) TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies. Acta Neuropathologica Communications 3:1.
Crossref
Nadine Bakkar, Ashley Boehringer & Robert Bowser. (2015) Use of biomarkers in ALS drug development and clinical trials. Brain Research 1607, pages 94-107.
Crossref
Hiroaki Suzuki, Yoshio Shibagaki, Seisuke Hattori & Masaaki Matsuoka. (2015) Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs. Human Molecular Genetics 24:6, pages 1513-1527.
Crossref
Annapurna Nayak, Gregory Salt, Sunil K. Verma & Uday Kishore. 2015. Omic Studies of Neurodegenerative Disease: Part A. Omic Studies of Neurodegenerative Disease: Part A 59 86 .
Thomas Krüger. 2015. General Methods in Biomarker Research and their Applications. General Methods in Biomarker Research and their Applications 1031 1052 .
Laura Robelin & Jose Luis Gonzalez De Aguilar. (2014) Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?. BioMed Research International 2014, pages 1-11.
Crossref
Thomas Krüger. 2014. General Methods in Biomarker Research and their Applications. General Methods in Biomarker Research and their Applications 1 18 .
Xenia Kobeleva & Susanne Petri. (2013) Barriers to novel therapeutics in amyotrophic lateral sclerosis. Neurodegenerative Disease Management 3:6, pages 525-537.
Crossref
Shigeto Nagao, Osamu Yokota, Chikako Ikeda, Seishi Terada, Yuetsu Ihara & Yosuke Uchitomi. (2013) Progressive supranuclear palsy presenting as primary lateral sclerosis. Journal of the Neurological Sciences 329:1-2, pages 70-71.
Crossref
Serena Lattante, Guy A. Rouleau & Edor Kabashi. (2013) TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update . Human Mutation 34:6, pages 812-826.
Crossref
Thomas Krüger, Janin Lautenschläger, Julian Grosskreutz & Heidrun Rhode. (2013) Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery. PROTEOMICS - Clinical Applications 7:1-2, pages 123-135.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.